Clinical trial
Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
NCT00054327 · Case Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00054327 |
|---|---|
| Title | Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer |
| Official title | Hematopoietic Stem Cell Transplantation Using Bone Marrow Or Peripheral Blood Stem Cells From Matched, Unrelated, Volunteer Donors |
| Lead sponsor | Case Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | busulfan, cyclophosphamide, cytarabine, radiation therapy, Etoposide, Stem Cell Transfusion |
| Enrollment | 34 |
| Start date | Nov 1, 2000 |
| Primary completion | Sep 1, 2011 |
| Completion | Sep 1, 2011 |
| First posted | Feb 6, 2003 |
| Last update posted | Jul 24, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: